Business News
Even foreign pharma companies are ditching DEIRoche and Novartis are the latest companies that are making changes to their DEI efforts
Updated March 19, 20252 min read
Roche and Novartis are the latest companies that are making changes to their DEI efforts
After falling 5.3% on Tuesday, Tesla stock got a boost
Plus: Nvidia and GM team up to make self-driving cars
Plus: Nvidia and GM team up to make self-driving cars
Plus: Nvidia and GM team up to make self-driving cars
Hims & Hers stock slides as regulators target off-brand GLP-1 drugs
2026 will be a big year for live events on NBC, including the Super Bowl and the Winter Olympics
A new study found that the cost of GLP-1 drugs like Wegovy and Zepbound is too high to justify their benefits
The recall is due to a crack on the bottle that can cause lacerations
Patients taking the affordable, off-brand versions of popular weight loss drugs made available during shortages are considering their next steps
The S&P 500 fell nearly 10% to about 5,578 since reaching a peak of 6,144 on Feb. 19
Plus, Eli Lilly's CEO got a pay raise, and Viking Therapeutics gets closer to bringing its Ozempic competitor to market
Comcast and the IOC are extending their partnership through 2036
After popping earlier this week, the companies behind the drugs are on a downward swing
The billionaire investor compared President Donald Trump's trade war to 1930s Germany
Plus: Gen Z loves collectibles
Plus: Gen Z loves collectibles
Plus: Gen Z loves collectibles
Sens. Warren, Wyden, and Sanders seek answers regarding RFK Jr. and President Trump's private Mar-a-Lago dinners with healthcare execs
The company just signed a deal with CordenPharma to help it mass produce its experimental weight loss drug
Plus: Amazon keeps giving Trump money